» Articles » PMID: 29274246

The Sarcopenia Index: A Novel Measure of Muscle Mass in Lung Transplant Candidates

Overview
Journal Clin Transplant
Specialty General Surgery
Date 2017 Dec 24
PMID 29274246
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Frailty, including low muscle mass, is an emerging risk factor for poor outcomes after lung transplant. The sarcopenia index (SI)-(serum creatinine value/cystatin C value) × 100-is a novel blood test to approximate muscle mass. We sought to validate SI among lung transplant patients.

Methods: We retrospectively identified adult lung transplant recipients from 2000 through 2012 at our institution who underwent computed tomography within 1 year before transplant and had preserved blood samples. Creatinine and cystatin C values were measured using the samples and used to calculate SI. Muscle mass was estimated by computed tomographic measurement of skeletal muscle cross-sectional surface area (SA) at the L1 to L3 vertebral levels. Correlation between SI and SA was evaluated.

Results: Of 28 patients meeting eligibility criteria, most were white (96%) and men (54%). Median (interquartile range) body mass index, SI, and SA were 25.9 (22-30) kg/m , 106 (91-119), and 157 (113-195) cm2, respectively. The Pearson correlation coefficient between SI and SA was significant at L2 (0.43; P = .02) and L3 (0.41; P = .03).

Conclusion: Sarcopenia index is a potentially objective measure for estimating muscle mass that is noninvasive and less expensive. Sarcopenia index could be considered in lung transplant candidate selection following prospective validation in larger cohorts.

Citing Articles

Oral Frailty and Its Relationship with Physical Frailty in Older Adults: A Longitudinal Study Using the Oral Frailty Five-Item Checklist.

Kusunoki H, Hasegawa Y, Nagasawa Y, Shojima K, Yamazaki H, Mori T Nutrients. 2025; 17(1.

PMID: 39796450 PMC: 11722929. DOI: 10.3390/nu17010017.


Identification of risk factors and development of a predictive nomogram for sarcopenia in Alzheimer's disease.

Chen S, Ou R, Wei Q, Fu J, Zhao B, Chen X Alzheimers Dement. 2025; 21(2):e14503.

PMID: 39778036 PMC: 11848345. DOI: 10.1002/alz.14503.


Current approach to the diagnosis of sarcopenia in cardiovascular diseases.

Han X, Zhang G, Li Q, Zhang Z Front Nutr. 2024; 11:1422663.

PMID: 39619285 PMC: 11604458. DOI: 10.3389/fnut.2024.1422663.


The Association between Serum Creatinine/Cystatin C Ratio and Cardiovascular Morbidity and Mortality: Insights from NHANES.

Shi J, Wu Y, Zhu S, Xie Y, Xiang M Rev Cardiovasc Med. 2024; 24(9):275.

PMID: 39076382 PMC: 11270077. DOI: 10.31083/j.rcm2409275.


Lower serum creatinine to cystatin C ratio associated with increased incidence of frailty in community-dwelling elderly men but not in elderly women.

Zhou S, Wang P, Sun L, Zhao X, Gong C, Yang Y Aging Clin Exp Res. 2024; 36(1):140.

PMID: 38965150 PMC: 11224078. DOI: 10.1007/s40520-024-02787-7.


References
1.
Christie J, Edwards L, Kucheryavaya A, Aurora P, Dobbels F, Kirk R . The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. J Heart Lung Transplant. 2010; 29(10):1104-18. DOI: 10.1016/j.healun.2010.08.004. View

2.
Rozenberg D, Wickerson L, Singer L, Mathur S . Sarcopenia in lung transplantation: a systematic review. J Heart Lung Transplant. 2014; 33(12):1203-12. DOI: 10.1016/j.healun.2014.06.003. View

3.
Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V . Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994; 40(10):1921-6. View

4.
Kashani K, Frazee E, Kukralova L, Sarvottam K, Herasevich V, Young P . Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index. Crit Care Med. 2016; 45(1):e23-e29. DOI: 10.1097/CCM.0000000000002013. View

5.
Kalantar-Zadeh K, Streja E, Kovesdy C, Oreopoulos A, Noori N, Jing J . The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc. 2010; 85(11):991-1001. PMC: 2966362. DOI: 10.4065/mcp.2010.0336. View